AMG National Trust Bank’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,000
Closed -$485K 270
2019
Q3
$485K Hold
5,000
0.03% 191
2019
Q2
$512K Hold
5,000
0.03% 195
2019
Q1
$569K Buy
+5,000
New +$367K 0.04% 179
2018
Q4
Sell
-5,000
Closed -$273K 263
2018
Q3
$273K Hold
5,000
0.02% 214
2018
Q2
$414K Hold
5,000
0.03% 197
2018
Q1
$333K Hold
5,000
0.02% 202
2017
Q4
$257K Hold
5,000
0.02% 209
2017
Q3
$446K Hold
5,000
0.03% 186
2017
Q2
$299K Hold
5,000
0.02% 210
2017
Q1
$267K Hold
5,000
0.02% 222
2016
Q4
$250K Hold
5,000
0.02% 219
2016
Q3
$300K Hold
5,000
0.03% 212
2016
Q2
$256K Buy
+5,000
New +$214K 0.02% 226
2016
Q1
Sell
-5,000
Closed -$227K 266
2015
Q4
$227K Buy
+5,000
New +$262K 0.02% 238

AMG National Trust Bank's ONCE Position: Q4 2019 in Review

AMG National Trust Bank sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 5,000 shares — an estimated $485K sold.

AMG National Trust Bank first reported a position in ONCE in Q4 2015 and held it in 14 quarters. The position peaked at $569K in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • AMG National Trust Bank reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • AMG National Trust Bank sold 5,000 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $485K.
  • AMG National Trust Bank first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 14 quarters.
  • AMG National Trust Bank's Spark Therapeutics, Inc. Common Stock position peaked at $569K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on AMG National Trust Bank's 13F filing for Q4 2019, filed 4 Feb 2020.